Swaminathan, Mahesh, and Farhad Ravandi. 2023. “Can Measurable Residual Disease Assessment Be Reliably Used to Defer Allogeneic Stem Cell Transplant in Patients With Intermediate-Risk Acute Myeloid Leukemia?”. Haematologica 108 (10). Pavia, Italy, 2561-63. https://doi.org/10.3324/haematol.2023.283120.